Evoke Pharma, Inc.
EVOK
$5.49
$0.081.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.57M | -1.31M | -1.19M | -1.31M | -1.27M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.00 | 226.80K | 403.60K | 506.90K | 1.90K |
| Change in Net Operating Assets | 1.01M | 81.90K | -450.90K | -13.20K | 444.70K |
| Cash from Operations | -565.00K | -997.50K | -1.24M | -818.70K | -820.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 25.00K | 3.48M | 3.00M | 295.70K |
| Repurchase of Common Stock | -- | -- | 0.00 | -200.00 | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 15.50K | -15.50K | 0.00 |
| Cash from Financing | 0.00 | 25.00K | 3.50M | 2.98M | 295.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -565.00K | -972.50K | 2.26M | 2.16M | -524.90K |